Results released in 4-year myopia control study of Diffusion Optics Technology in children
The research findings supported the hypothesis that a mild reduction in retinal contrast can slow myopia progression in young children.
Navigating AI in optometry: A balancing act of innovation and ethics
How to be optimistic, responsible, and open in the face of new technology.
EyePoint begins dosing in second global Phase 3 LUCIA clinical trial of Duravyu for the treatment of wet AMD
The study evaluates Duravyu’s efficacy, durability, and re-dosing every 6 months in both treatment-naïve and previously treated patients.
Bausch + Lomb acquires ELIOS system, expanding glaucoma treatment options
The ELIOS system is a laser-based technology that offers a new approach to treating glaucoma, particularly in conjunction with cataract surgery.
Lifitegrast improves clinical signs and biomarkers of patients with DED: A Q&A with Dr. James Thimons
All 6 biomarkers in the study demonstrated improvement with the treatment of lifitegrast, according to Thimons.
Galimedix Therapeutics initiates Phase 1 trial of oral GAL-101
The company begins phase 1 trials of oral GAL-101, targeting amyloid beta aggregation for potential treatment of dry AMD, glaucoma, and neurodegenerative eye diseases.
Think outside the wallet when choosing benefit options for your employees
Don’t mistake financial feasibility as the sole decider in employee enrollment.
Ocular Therapeutix randomizes more than 300 patients in SOL-1 Phase 3 trial for OTX-TKI
The trial is expected to close randomization in early December 2024.
What will myopia control look like in 2034?
New long-term findings illuminate the future of DIMS spectacle lenses.
What happened in optometry this week: December 2 - December 6
Catch up on what happened in optometry during the week of December 2-December 6.
Study investigates PROSE lenses as drug delivery device for patients with dry eye disease
The study found that the prosthetic replacement of the ocular surface ecosystem lenses were well tolerated in the delivery of non-preserved cyclosporine 0.05%.
Study evaluates ocular tuberculosis and relapse rates for recurrence of uveitis
Relapse and chronic uveitis can occur after infectious uveitis was treated successfully, study authors found.
Does lifitegrast improve dry eye symptoms for contact lens wearers?
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
You and Eye: Vision training research in eSports - with Tiffany Tsoi, OD, FAAO
Tiffany Tsoi, OD, FAAO, shares insights on the world of visual training research for eSports athletes.
The vitreous—remember me?
Watching out for inevitable degenerative changes can improve patient care.
Eying the future: New school program seeks to fuel student interest in optometry
BMI, tobacco, and alcohol: Roles in glaucoma progression examined in study
The primary findings were that a higher BMI was protective against glaucoma progression and use of tobacco and alcohol were not significantly associated with retinal nerve fiber layer change.
Factors influencing ocular pain in patients with dry eye in Tibet
The retrospective study investigated and analyzed the severity and frequency of ocular pain and factors affecting it among DED patients living in high altitudes above 2500 meters during the COVID-19 pandemic.
Prevent Blindness names first week of December 2024 Geographic Atrophy Awareness Week
The organization will provide resources for spreading awareness and educating patients and care givers.
Is there a relationship between keratoconus and diabetes?
Studies point to an inverse association between diabetes and keratoconus risk.
.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Physician filling injection needle Image credit: ©REDPIXEL - adobe.stock.com")
.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Graphic of work-life balance scale Image credit: AdobeStock/Ibrahim")
.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Woman sitting at OCT machine Image credit: AdobeStock/Parilov")
